Literature DB >> 11929834

Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies.

Yael Hegerfeldt1, Miriam Tusch, Eva-B Bröcker, Peter Friedl.   

Abstract

Collective cell movement represents an efficient dissemination strategy in neoplastic epithelial and mesenchymal cancer. In primary melanoma explants cultured in three-dimensional collagen lattices, invasive migration of multicellular clusters was dependent on the function of beta1 integrins, as shown by preferential beta1-integrin expression and clustering in a subset of promigratory cells at the leading edge ("guiding cells") and the abrogation of multicellular migration by adhesion-perturbing anti-beta1-integrin antibody. Interference with beta1-integrin function induced complex changes in cluster polarity and cohesion, including development of two or several opposing leading edges, cluster disruption, and the detachment of individual cells followed by beta1-integrin-independent "amoeboid" crawling and dissemination. The conversion from beta1-integrin-dependent collective movement to beta1-integrin-independent single-cell motility suggests efficient cellular and molecular plasticity in tumor cell migration strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929834

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  126 in total

1.  Dynamic imaging of cellular interactions with extracellular matrix.

Authors:  Peter Friedl
Journal:  Histochem Cell Biol       Date:  2004-07-16       Impact factor: 4.304

2.  N-cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix.

Authors:  Wenting Shih; Soichiro Yamada
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

3.  A steering model of endothelial sheet migration recapitulates monolayer integrity and directed collective migration.

Authors:  Philip Vitorino; Mark Hammer; Jongmin Kim; Tobias Meyer
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

4.  EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.

Authors:  Katie E Foster; Julie Gordon; Kim Cardenas; Henrique Veiga-Fernandes; Taija Makinen; Elena Grigorieva; David G Wilkinson; C Clare Blackburn; Ellen Richie; Nancy R Manley; Ralf H Adams; Dimitris Kioussis; Mark C Coles
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-08       Impact factor: 11.205

5.  Myosin-IXA regulates collective epithelial cell migration by targeting RhoGAP activity to cell-cell junctions.

Authors:  Tatiana Omelchenko; Alan Hall
Journal:  Curr Biol       Date:  2012-02-02       Impact factor: 10.834

6.  Quantitative assessment of local collagen matrix remodeling in 3-D culture: the role of Rho kinase.

Authors:  Areum Kim; Neema Lakshman; W Matthew Petroll
Journal:  Exp Cell Res       Date:  2006-08-16       Impact factor: 3.905

7.  Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis.

Authors:  Wei Yu; Xiaohui Fang; Andrew Ewald; Kit Wong; C Anthony Hunt; Zena Werb; Michael A Matthay; Keith Mostov
Journal:  Mol Biol Cell       Date:  2007-03-01       Impact factor: 4.138

8.  Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.

Authors:  Lipsa Das; Jaime M C Gard; Rytis Prekeris; Raymond B Nagle; Colm Morrissey; Beatrice S Knudsen; Cindy K Miranti; Anne E Cress
Journal:  Mol Cancer Res       Date:  2018-05-14       Impact factor: 5.852

Review 9.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover.

Authors:  Neil O Carragher
Journal:  Clin Exp Metastasis       Date:  2008-10-29       Impact factor: 5.150

10.  On-chip open microfluidic devices for chemotaxis studies.

Authors:  Gus A Wright; Lino Costa; Alexander Terekhov; Dawit Jowhar; William Hofmeister; Christopher Janetopoulos
Journal:  Microsc Microanal       Date:  2012-08       Impact factor: 4.127

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.